Free tool
Company pipelines
Each company page lists its approved NDAs and BLAs, its expedited approvals, and its registered drug trials by phase, a public view of its pipeline. Large companies are merged across the names they file under; for everyone else the Drugs@FDA sponsor name is used as written.
Last checked: Nov 18, 2026Source: Drugs@FDA, ClinicalTrials.gov
Large drug developers
Ranked by novel approvals in Drugs@FDA, including acquired companies' drugs.
| Company | Novel approvals | NDAs and BLAs | Still marketed |
|---|---|---|---|
| PfizerPFE | 130 | 423 | 168 |
| NovartisNVS | 86 | 224 | 116 |
| AbbVieABBV | 62 | 198 | 83 |
| SanofiSNY | 62 | 113 | 43 |
| Merck & Co.MRK | 59 | 145 | 47 |
| Johnson & Johnson (Janssen)JNJ | 51 | 131 | 60 |
| Roche (Genentech)RHHBY | 51 | 95 | 49 |
| GSKGSK | 49 | 148 | 57 |
| Eli LillyLLY | 44 | 91 | 40 |
| Bristol Myers SquibbBMY | 41 | 75 | 37 |
| AstraZenecaAZN | 39 | 84 | 47 |
| TakedaTAK | 33 | 63 | 40 |
| BayerBAYRY | 32 | 99 | 51 |
| Gilead SciencesGILD | 21 | 38 | 33 |
| Boehringer Ingelheim | 21 | 54 | 28 |
| AmgenAMGN | 20 | 40 | 31 |
| TevaTEVA | 18 | 77 | 30 |
| AstellasALPMY | 15 | 27 | 15 |
| UCB | 11 | 30 | 18 |
| BiogenBIIB | 10 | 12 | 12 |
| Otsuka | 9 | 64 | 55 |
| Eisai | 9 | 15 | 11 |
| RegeneronREGN | 8 | 9 | 9 |
| Vertex PharmaceuticalsVRTX | 7 | 10 | 9 |
| BioMarinBMRN | 7 | 8 | 8 |
| Novo NordiskNVO | 6 | 20 | 16 |
| Daiichi SankyoDSNKY | 6 | 7 | 6 |
| Jazz PharmaceuticalsJAZZ | 6 | 11 | 9 |
| IncyteINCY | 5 | 6 | 6 |
| Alnylam PharmaceuticalsALNY | 4 | 4 | 4 |
| BeOne Medicines (BeiGene)ONC | 3 | 6 | 5 |
| Ionis PharmaceuticalsIONS | 3 | 3 | 3 |
| Neurocrine BiosciencesNBIX | 2 | 4 | 4 |
| argenxARGX | 1 | 2 | 2 |
| ModernaMRNA | 0 | 0 | 0 |
Other sponsors
By novel approvals, as named in Drugs@FDA.
- Bausch22 novel · 76 total
- Organon22 novel · 57 total
- Ge Healthcare18 novel · 47 total
- Bracco13 novel · 44 total
- Bausch and Lomb11 novel · 31 total
- Abbott10 novel · 30 total
- Pf Prism Cv10 novel · 16 total
- Legacy10 novel · 16 total
- Waylis Therap10 novel · 12 total
- Azurity9 novel · 56 total
- Chiesi9 novel · 17 total
- Valeant Pharms Intl9 novel · 16 total
- Baxter Hlthcare8 novel · 120 total
- Alcon Labs INC8 novel · 32 total
- Upjohn8 novel · 13 total
- Recordati Rare8 novel · 12 total
- Advanz Pharma8 novel · 11 total
- Hikma7 novel · 56 total
- Emd Serono7 novel · 20 total
- King Pharms LLC7 novel · 19 total
- Sun Pharm Inds INC6 novel · 25 total
- Viatris6 novel · 24 total
- Cosette6 novel · 23 total
- Mallinckrodt INC6 novel · 17 total
- Cheplapharm6 novel · 15 total
- Validus Pharms6 novel · 12 total
- Shionogi6 novel · 8 total
- Fresenius Kabi USA LLC5 novel · 50 total
- Fougera5 novel · 19 total
- Endo Operations5 novel · 18 total
- Novo5 novel · 10 total
- Almirall5 novel · 8 total
- Cubist Pharms LLC5 novel · 7 total
- Ipsen5 novel · 6 total
- Vanda Pharms INC5 novel · 6 total
- Guerbet5 novel · 5 total
- Galderma Labs Lp4 novel · 27 total
- Ani Pharms4 novel · 23 total
- Ferring Pharms INC4 novel · 23 total
- Ph Health4 novel · 20 total
- Lederle4 novel · 19 total
- Apothecon4 novel · 17 total
- Curium4 novel · 16 total
- Apotex4 novel · 15 total
- Rising4 novel · 13 total
- Leo Pharma As4 novel · 12 total
- Pai Holdings4 novel · 12 total
- Leadiant Biosci INC4 novel · 8 total
- Tersera4 novel · 8 total
- Lundbeck Pharms LLC4 novel · 7 total
- Mission Pharma4 novel · 7 total
- Lantheus Medcl4 novel · 5 total
- Helsinn Hlthcare4 novel · 5 total
- Rigel Pharms4 novel · 4 total
- Kyowa Kirin4 novel · 4 total
- Pharmobedient3 novel · 22 total
- Harrow Eye3 novel · 21 total
- Mylan Pharms INC3 novel · 19 total
- Sun Pharma Global3 novel · 18 total
- Salix3 novel · 17 total
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.